Senores Pharmaceuticals Limited company information, Employees & Contact Information

Senores Pharma appoints Sanjay Moralwar as Head of IT Medical Dialogues

Senores Pharma gains on US ANDA acquisition from Teva Business Standard

Senores Pharmaceuticals IPO Day 3 Highlights: Issue booked 93.41 times on third day; check GMP & other details Mint

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market Business Wire

Why Senores Pharma Share Price is Rising Equitymaster

Ahmedabad-based Senores Pharma to use ₹107 cr from IPO proceeds for new unit in United States BusinessLine

Senores Pharma hits all time high on posting Q1 results; PAT up 95% YoY Business Standard

Senores Pharmaceuticals IPO Day 1: Latest GMP, subscription status, review, other details. Apply or not? Mint

Senores Pharmaceuticals, Inc. announces the launch of Mexiletine Hydrochloride Capsules USP, 150 mg, 200 mg and 250 mg with one of the top generic pharmaceutical companies in the U.S. market PR Newswire

Senores Pharmaceuticals IPO Date, Review, Price, Allotment Details IPO Watch

Senores Pharma Acquires 14 ANDAs from Dr Reddy's Rediff MoneyWiz

Senores Pharma up 4% as board approves acquisition of 3.73% stake in Havix Business Standard

Senores Pharmaceuticals Day 1 Updates: Issue subscribed 1.86 times, GMP at ₹180 Mint

Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg in the U.S. market PR Newswire

Broker’s call: Senores Pharma (Buy) BusinessLine

Senores Pharmaceuticals IPO listing date today. GMP, experts signal up to 70% gain for share allottees Mint

Senores Pharma up 7% on acquiring 14 ANDAs from Dr. Reddy's Laboratories Business Standard

Cintex Services, LLC and Senores Pharmaceuticals, Inc. launch Chlorzoxazone Tablets USP, 250 mg in the U.S. market PR Newswire

Senores Pharma share price hits record high rising 13% on Q1 results 2025. Doubles allottees' money in seven months Mint

Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from Wockhardt The Economic Times

Senores Pharma has niche positives, can be a long-term bet The Economic Times

Senores Pharma Files IPO Papers To Raise Rs 500 Crore NDTV Profit

Senores Pharmaceuticals IPO GMP, Price, Allotment, Profit Estimate 2024 IPO Central

Senores Pharma shares list at 53% premium over IPO price The Economic Times

Senores Pharma shares jump over 7% as company acquires 14 ANDAs from Dr. Reddy’s Moneycontrol

Senores Pharma IPO: GMP, subscription status, review, other details. Apply or not? Mint

Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion CNBC TV18

Senores Pharmaceuticals Share Price Live: Senores Pharma shares drop 10% post debut; list at 53% premium ... The Economic Times

Senores Pharma IPO Opens on Friday: Rs 582 Crore Issue Rediff MoneyWiz

Senores Pharma Standalone June 2025 Net Sales at Rs 19.82 crore, up 164.97% Y-o-Y Moneycontrol

Senores Pharma rises 6% after its arm inks agreement to acquire Roflumilast Business Standard

Senores Pharma IPO listing jackpot: Shares debut at bumper 52% premium Business Standard

Senores Pharma files IPO with Sebi, aims to raise Rs 500 cr via fresh issue Business Standard

IPO corner: Senores Pharma subscribed 93x; Carraro 1.1x, Ventive 10x Business Standard

Senores Pharma eyes strong growth in contract manufacturing, revenue boost from Dr Reddy’s deal CNBC TV18

Senores Pharma begins Greenfield API manufacturing facility in Gujarat Business Standard

Senores Pharma IPO: Check allotment status, GMP, listing price and date BusinessLine

Stock Radar: Investors book profits in Senores Pharma after hitting record high in July 2025; should you b The Economic Times

Senores Pharma IPO GMP soars to 60% on final day of bidding; issue concludes with 93 times subscription Moneycontrol

Senores Pharma IPO opens for subscription; should you bet on this pharma name? Business Today

Senores Pharmaceuticals Share Price Target 2025, 2026, 2030, 2050 shareprice-target.com